Innocan Pharma (INNPF) FCF Margin (2024 - 2025)
Innocan Pharma (INNPF) reported FCF Margin of 0.12% for the quarter ended Dec 31, 2025, up 0.05 percentage points from 0.07% a year earlier but down 0.26 percentage points from the prior quarter.
Powered by 
Analysis
Innocan Pharma (INNPF) FCF Margin (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Innocan Pharma posted FCF Margin of 0.06%, up 0.01 percentage points from the prior year.
- By year, FCF Margin came in at 0.05% in the year ended Dec 31, 2024 (+28.30 pp) and -28.25% in the year ended Dec 31, 2023.
- Five-year quarterly FCF Margin spans a low of -11.56% in the quarter ended Sep 30, 2024 and a high of 9.81% in the quarter ended Jun 30, 2025.
- Year over year, FCF Margin has now increased in each of the last four quarters, with an average year-over-year change of +7.44 percentage points over the last four quarters.
- Per Business Quant data, the three quarters before the quarter ended Dec 31, 2025 came in at 0.38% (quarter ended Sep 30, 2025), 9.81% (quarter ended Jun 30, 2025) and 4.78% (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 28.96% |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 0.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.12% |
| Sep 30, 2025 | 0.38% |
| Jun 30, 2025 | 9.81% |
| Mar 31, 2025 | 4.78% |
| Dec 31, 2024 | 0.07% |
| Sep 30, 2024 | -11.56% |
| Jun 30, 2024 | 7.84% |
| Mar 31, 2024 | -11.01% |
API Access
Innocan Pharma FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();